vorinostat has been researched along with Adrenocorticotropic Hormone, Inappropriate Secretion in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, J | 1 |
| Chatain, GP | 1 |
| Bugarini, A | 1 |
| Wang, X | 1 |
| Maric, D | 1 |
| Walbridge, S | 1 |
| Zhuang, Z | 1 |
| Chittiboina, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation and Treatment of Neurosurgical Disorders[NCT00060541] | 5,000 participants (Anticipated) | Observational | 2003-06-04 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for vorinostat and Adrenocorticotropic Hormone, Inappropriate Secretion
| Article | Year |
|---|---|
Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Animals; Apoptosis; Blotting | 2017 |